SBIR/STTR Research Award

RECAL:A New Tool for Disease Detection and Biomolecular Imaging

Award identifier 29b5b9616a96454bc76e857cb3b1eeb9417dcf25cfa909f0b8a3941c6b4da490Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Photon Biosciences LLC
Proposal award date
2018-04-01
Contract end date
2019-03-31
UEI
H4E3QZYNTHD1
Solicitation number
PA16-302
Topic code
400

Research abstract

Project SummaryAbstract We envision developing a new ultrasensitive detection platform that combines a recombinant protein with a unique imaging media that results in a luminescent protein that is non bleaching and non blinkingThe excitation and emission wavelengths of this protein can be tuned with the choice of imaging media and span much of the visible and near infrared regions of the electromagneticWe will refer to this new platform as RECALRECALemits light as phosphorescencebut its unique properties result in an overall luminescence intensity that rivals and surpasses many fluorescent organic molecules and can be engineered into a luminescent upconversion probes in which IR excitation will lead to visible luminescenceThis will surely allow for the effective use of RECALas a medical diagnostic tool in tissuebloodand urine samples or environmentalhomeland security devices to name but a fewThis proposal has three aimsAimDevelop the RECALinto a microscale ELISA based medical diagnostic kit for markersassociated with liver function and compare its superior sensitivity and marketability to that ofstate of the art ELISA based medical diagnostic kits in the current marketAimTest the feasibility of using RECALas a recombinant in vivo imaging technology and exploitits long luminescent lifetime and photochemical stability to suppress unwanted background inorder to increase its sensitivity over existing GFP fusion technologiesAimExploit the unique photophysics of associated with RECALto develop biomolecular imagingtechnology that absorbs multiple IR photons resulting in visible luminescenceOur goal is to develop commercially viable RECALproducts that will have far reaching benefits for medical diagnosticsbiomedical researchhomeland securityand ultimately human health RECALis a new ultrasensitive detection platform that combines a recombinant protein with unique imaging media that results in a luminescent protein that is non bleachingnon blinkingand has a luminescence intensity that rivals and surpasses many fluorescent organic moleculesThe excitation and emission wavelengths of this protein can be tuned with the choice of imaging media and span much of the visible and near infrared regions of the electromagneticBecause of its unique photophysical propertiesRECALwill be developed into ultrasensitive medical diagnostic and forensic technologies and probes for bimolecular imaging

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2018–2024). Reported award amounts total $1,014,129. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.